Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185
出版年份 2015 全文链接
标题
Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185
作者
关键词
MicroRNA-185, Somatostatin analog, Somatostatin receptor subtype 2, GH-secreting pituitary adenoma
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 38, Issue 10, Pages 1117-1128
出版商
Springer Nature
发表日期
2015-06-03
DOI
10.1007/s40618-015-0306-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-185 Inhibits Hepatocellular Carcinoma Growth by Targeting the DNMT1/PTEN/Akt Pathway
- (2014) Ximena V. Qadir et al. AMERICAN JOURNAL OF PATHOLOGY
- Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage
- (2013) Qiaoming Zhi et al. BIOMEDICINE & PHARMACOTHERAPY
- A Novel Marine Drug, SZ-685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR-200c
- (2013) C.-H. Chen et al. CURRENT MEDICINAL CHEMISTRY
- MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor
- (2013) Fajun Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells
- (2013) Xiangyan Li et al. PLoS One
- LRRC4 Inhibits Glioma Cell Growth and Invasion Through a miR-185- Dependent Pathway
- (2012) Hailin Tang et al. CURRENT CANCER DRUG TARGETS
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Dopamine agonist–resistant prolactinomas
- (2011) Michael C. Oh et al. JOURNAL OF NEUROSURGERY
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers
- (2010) J S Imam et al. ONCOGENE
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
- (2009) Anat Ben-Shlomo et al. MOLECULAR ENDOCRINOLOGY
- Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment
- (2009) Ana Paula M. Casarini et al. Pituitary
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started